U.S. Markets open in 1 hr 2 mins
S&P Futures
2,445.00
-7.75 (-0.32%)Dow Futures
21,828.00
-58.00 (-0.27%)
| Previous Close | 72.60 |
| Open | 72.66 |
| Bid | 73.12 x 200 |
| Ask | 73.57 x 200 |
| Day's Range | 72.65 - 73.76 |
| 52 Week Range | 63.76 - 82.10 |
| Volume | 4,729,252 |
| Avg. Volume | 8,745,668 |
| Market Cap | 95.78B |
| Beta | 1.08 |
| PE Ratio (TTM) | 7.75 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.87%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Motley Fool•25 minutes ago
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences
AbbVie is a better dividend stock than Gilead Sciences for obvious and not-so-obvious reasons.
- Zacks•21 hours ago
Alkermes Initiates Rolling Submission of Depression Drug
Alkermes (ALKS) initiated the rolling submission of a New Drug Application (NDA) to the FDA for pipeline candidate ALKS 5461 for major depressive disorder.
- Zacks•22 hours ago
4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
Here is a look at four biotech stocks including Gilead (GILD) that topped estimates in Q2 and are witnessing upward estimate revisions for the current year.
